Pilot Growth Equity

Bizzabo Ltd. is a cloud-based platform that specializes in event management, designed for in-person, hybrid, and virtual events. Established in 2011 and headquartered in Tel Aviv-Yafo, Israel, Bizzabo provides a comprehensive suite of tools to facilitate various aspects of event planning, including registration, ticketing, marketing, agenda management, networking, and sponsorship opportunities. The platform aims to enhance the event experience for organizers, attendees, sponsors, and speakers, and is utilized by notable brands such as HubSpot, Forbes, and Uber. Bizzabo operates on a subscription model, charging an annual fee along with a per-registration fee. The company has received multiple accolades, recognizing its contributions to event technology and workplace culture.

Tailwind is the visual marketing platform, loved by over 100,000 brands and influencers worldwide. Tailwind helps you create, manage and optimize smarter, more effective campaigns on leading visual platforms, such as Instagram and Pinterest. Tailwind members have been shown to generate 4x more engagement on their content than those who go without Tailwind.

r4 Technologies specializes in cross-enterprise artificial intelligence, providing a platform that enables organizations to harness growth opportunities hidden within and across their various systems and processes. By integrating data from diverse sources within the enterprise and supplementing it with external information, r4 creates comprehensive models that reveal new revenue opportunities. The platform employs advanced analytics to deliver predictions and tailored recommendations that can be seamlessly integrated back into existing enterprise systems. Founded by the creators of Priceline.com, r4 applies their expertise in predictive algorithms and data extraction to support large companies in driving growth and gaining competitive advantages. The company is headquartered in Connecticut, with additional operations in Metropolitan New York, San Francisco, Austin, Washington, D.C., and Dublin, as well as presences in Munich and London.

Bizzabo Ltd. is a cloud-based platform that specializes in event management, designed for in-person, hybrid, and virtual events. Established in 2011 and headquartered in Tel Aviv-Yafo, Israel, Bizzabo provides a comprehensive suite of tools to facilitate various aspects of event planning, including registration, ticketing, marketing, agenda management, networking, and sponsorship opportunities. The platform aims to enhance the event experience for organizers, attendees, sponsors, and speakers, and is utilized by notable brands such as HubSpot, Forbes, and Uber. Bizzabo operates on a subscription model, charging an annual fee along with a per-registration fee. The company has received multiple accolades, recognizing its contributions to event technology and workplace culture.

Counsyl is a health technology company specializing in DNA screening for individuals and families. Its services aim to provide critical health information that can influence important decisions regarding behavior, prevention, and preparedness for future health challenges. By leveraging advanced technology, including custom-built robotics and a team of scientists and engineers, Counsyl processes blood and saliva samples with high precision and efficiency. The company has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals, striving to make DNA screening accessible to a broad audience. Counsyl’s innovative approach has earned recognition, including the Wall Street Journal’s Innovation Award for Medicine, and its Family Prep Screen has significantly aided individuals in understanding crucial genetic information prior to childbearing. The platform has expanded its offerings to include informed pregnancy and cancer screening, emphasizing the integration of sophisticated technology in real-time communication of medical results between patients and healthcare providers.

Webgility makes business easier for ecommerce sellers. Webgility Unify software reduces effort and inefficiencies for sellers by automating their back-end busywork and improving their operational workflows. Webgility Unify deliver business insights that sellers need every morning. The Webgility team is headquartered in San Francisco with a development center in India.

Metabiota, Inc. focuses on assessing and investigating infectious disease threats through pathogen discovery, disease detection, and threat characterization. Founded in 2008 and headquartered in San Francisco, California, the company provides data, analytics, and training aimed at preparing for global health threats and minimizing their impacts. Metabiota's services include surveillance, recognition, and diagnosis of microbial threats, which assist in reducing and preventing outbreaks. The company employs a strategic global presence and fosters partnerships to help local authorities develop effective mitigation strategies, thereby enabling governments and organizations to better manage and respond to infectious disease risks.

Velocidi is a customer data platform based in New York, with an additional office in Porto, Portugal. The company specializes in providing a private CDP that operates within each client's own infrastructure, resembling an in-house solution. Velocidi serves direct-to-consumer brands by enabling them to collect and unify first-party customer data from both online and offline sources. The platform utilizes machine learning to analyze customer behavior and predict future actions, allowing brands to optimize their marketing efforts in real-time. Additionally, Velocidi facilitates the direct activation of audience segments on various advertising platforms, ensuring clients maintain complete ownership and control over their data.

Leveraging its trusted, Cloud-based, globally distributed platform, its patent-pending monitoring and mitigation technology, and its unparalleled expertise in cyberattack mitigation, Zenedge provides organizations an enterprise-class, managed white-glove cybersecurity service to help secure their web sites, web applications, and networks against vulnerabilities and Distributed Denial of Service (DDoS) attacks. Unlike other Web Application Security solutions in the market, Zenedge leverages patent-pending deep machine-learning capabilities to detect anomalies, dynamically alter security postures, and initiate auto-mitigation and automatic routing with minimal to zero human intervention. This allows the company to provide better cybersecurity and faster time to mitigation than traditional Cloud and on-premise cybersecurity vendors.

Perthera is the leading company in personalized therapy for patients with cancer. Perthera uses advanced, commercially available tests to provide oncologist the most complete information available today for fighting cancer. Recent breakthroughs in cellular protein analysis (proteomics) and gene profiling (genomics) make it possible for Perthera to more completely understand the nature and progression of your cancer. There are many new tests available that can give them insight into the disease, and they select the best available tests to obtain a comprehensive disease profile.

CB Insights, previously known as ChubbyBrain, is your personalized gateway to smarter, faster, friendlier intelligence on high growth private companies. CB insights is the ideal tool for those engaged in private equity, venture capital, corporate development, investment banking, corporate innovation & strategy, angel investment and consulting. Whether it is deal sourcing, due diligence, or market and competitive intelligence, CBI has been created to assist you in discovering the right private company information in the most efficient, comprehensive way.

Metabiota, Inc. focuses on assessing and investigating infectious disease threats through pathogen discovery, disease detection, and threat characterization. Founded in 2008 and headquartered in San Francisco, California, the company provides data, analytics, and training aimed at preparing for global health threats and minimizing their impacts. Metabiota's services include surveillance, recognition, and diagnosis of microbial threats, which assist in reducing and preventing outbreaks. The company employs a strategic global presence and fosters partnerships to help local authorities develop effective mitigation strategies, thereby enabling governments and organizations to better manage and respond to infectious disease risks.

Metabiota, Inc. focuses on assessing and investigating infectious disease threats through pathogen discovery, disease detection, and threat characterization. Founded in 2008 and headquartered in San Francisco, California, the company provides data, analytics, and training aimed at preparing for global health threats and minimizing their impacts. Metabiota's services include surveillance, recognition, and diagnosis of microbial threats, which assist in reducing and preventing outbreaks. The company employs a strategic global presence and fosters partnerships to help local authorities develop effective mitigation strategies, thereby enabling governments and organizations to better manage and respond to infectious disease risks.

Counsyl is a health technology company specializing in DNA screening for individuals and families. Its services aim to provide critical health information that can influence important decisions regarding behavior, prevention, and preparedness for future health challenges. By leveraging advanced technology, including custom-built robotics and a team of scientists and engineers, Counsyl processes blood and saliva samples with high precision and efficiency. The company has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals, striving to make DNA screening accessible to a broad audience. Counsyl’s innovative approach has earned recognition, including the Wall Street Journal’s Innovation Award for Medicine, and its Family Prep Screen has significantly aided individuals in understanding crucial genetic information prior to childbearing. The platform has expanded its offerings to include informed pregnancy and cancer screening, emphasizing the integration of sophisticated technology in real-time communication of medical results between patients and healthcare providers.